Webinar Recording for -
Advances in In Vitro Bioequivalence Assessment for Topical Products - Science, Best Practices, and Regulatory Challenges (FDA vs EMA) IVPT Focus

If you are involved in topical formulations (innovator and generics), you’ll benefit from this webinar as well as those in R&D, regulatory affairs, quality assurance, quality control, and academics.

During this comprehensive webinar, we’ll provide insights into:

• The main objectives, principles and methodologies of an IVPT study
• The role of IVPT method as a surrogate alternative
• Membrane, media and permeation enhancers for IVPT
• Current challenges and future perspectives topical product bioequivalence
• Case studies providing practical, real-world examples of IVPT

The presenter is Dr. Theo Kapanadze, co-founder and chief scientific officer of Diteba Inc., a leader in dermal and transdermal research services. Diteba has been pivotal in advancing drug development and securing numerous innovator and generic drug approvals. Dr. Kapanadze has 20-plus years of research experience in analytical R&D chemistry and the pharmaceutical, biopharmaceutical, and nutraceutical industries. He earned his Ph.D. and D.Sc. in the chemistry of biological active compounds.

Complete the form on the right to receive the link to the full recording.